Brief: Eton Pharmaceuticals Acquires Galzin
03/01/2025 11:52
Jan 3 (Reuters) - Eton Pharmaceuticals Inc ETON.O :
* ETON PHARMACEUTICALS ADVANCES ITS COMMITMENT TO RARE
DISEASE
WITH THE ACQUISITION OF GALZIN®
* ETON PHARMACEUTICALS INC - TO COMMERCIALIZE GALZIN IN U.S.
IN Q1
2025
* ETON PHARMACEUTICALS INC: HAS ALSO ACQUIRED EUROPEAN
RIGHTS TO
GALZIN
Source text: ID:nGNX1LkkCW
Further company coverage: ETON.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Eton Pharmaceuticals
See all newsBrief: Eton Pharmaceuticals Under Agreement, Co Pays Aquestive Upfront License Fee Of $10 Million - SEC Filing
Aquestive rises on US licensing deal for seizure drug with Eton Pharma
U.S. STOCKS ON THE MOVE-Sun Communities, Cisco Systems, Paysafe
U.S. STOCKS ON THE MOVE-Fox, Sun Communities, Reddit, drone firms
U.S. STOCKS ON THE MOVE-Boost Run, Nektar Therapeutics, Swarmer